SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-24-004686
Filing Date
2024-01-16
Accepted
2024-01-16 17:00:10
Documents
12
Period of Report
2024-01-16
Items
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K allk-20240116.htm   iXBRL 8-K 50300
2 EX-99.1 allk-ex99_1.htm EX-99.1 37392
3 EX-99.2 allk-ex99_2.htm EX-99.2 49799
  Complete submission text file 0000950170-24-004686.txt   263011

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT allk-20240116.xsd EX-101.SCH 23882
6 EXTRACTED XBRL INSTANCE DOCUMENT allk-20240116_htm.xml XML 4513
Mailing Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD SUITE 500 SAN CARLOS CA 94070 650-597-5002
Allakos Inc. (Filer) CIK: 0001564824 (see all company filings)

IRS No.: 454798831 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38582 | Film No.: 24535817
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)